Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services.
OUR STORY
For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions.
Our integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements.
Our shared goal: to help you make educated, faster and more complete early phase drug development decisions — to speed you to proof of concept and beyond.
OUR UNIQUE APPROACH
At Altasciences, we provide you with clear, customized roadmaps, supported by our real-time data generation, proprietary communication platform, and central program management and scheduling to help you get to clinical proof of concept, faster.
OUR PURPOSE
Our purpose is to help you research and develop potentially life-saving therapeutics — and get you there faster, with integrated CRO/CDMO services, always moving in unison for maximum efficiency. Our commitment to quality, excellence, integrity, and respect help us deliver big impact with a personal touch.
Altasciences has strategically placed research and manufacturing facilities across North America.
Our clinical trial facilities include adaptive Phase 1 and 2 clinical pharmacology units for healthy normal participant and patient population studies, as well as capabilities for specialized assessments such as driving simulation, human abuse potential, for large and small molecules.
Our preclinical research facilities include 250,000 square feet of purpose-built space, where we conduct comprehensive regulatory safety testing, bioanalysis, and other research support services in a wide range of species for both small and large molecules.
We have state-of-the-art bioanalytical laboratories, including LC-MS/MS and a dedicated ligand binding large molecule lab, with over 200 specialized analysts available 24/7, according to program needs. We use the latest equipment, technologies, and advanced methods, and have the capacity to process over 60,000 study samples per month.
Our 64,000 square-foot CDMO formulation, manufacturing and analytical campus includes an analytical lab, R&D formulations lab, multiple manufacturing suites including segregated and dedicated Schedule I and potent handling capabilities, and warehouse space.